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Short Communication
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A number of recent studies on acute leukaemia
have focused on pretreatment factors that are of
prognostic significance in determining the likelihood
of achieving complete remission, remission duration
or length of survival. Even so, it has been difficult
to identify convincing clinical or haematological
criteria for predicting the response to cytostatic
drugs. Determination of colony formation has
become a useful tool for investigating the abnormal
regulation of haematopoiesis. Therefore, several
investigators have tried to correlate the in vitro
growth pattern of granulopoietic progenitor cells
with the prognostic outcome (Keating et al., 1980;
Elias & Greenberg, 1977; Moore et al., 1974;
Hornsten et al., 1977; Beran et al., 1980; Gustavsson
et al., 1981). However, the results have been
conflicting due to poor reproducibility and
differences in culture technique, sources of colony
stimulating activity, classification of growth pattern,
therapeutic regimens, selection of patients, and
inadequate statistical analysis. The objective of the
present study was (a) to investigate in each patient
with acute myelogenous (AML) and lymphocytic
leukaemia (ALL), the in vitro colony-forming
capacity of both bone marrow and peripheral blood
at first diagnosis, during induction treatment, in
remission and relapse; and (b) to evaluate the
prognostic utility of this in vitro assay in respect of
rate of remission, remission duration, and length of
survival.
Fifty consecutive, previously untreated adults
with acute leukaemia were investigated over a 2yr-
period; 31 were cases of AML and 19 were of ALL.
The morphological and immunological variants as
well as clinical details are summarized in Table I.
For remission induction, AML-patients were treated
with adriamycin i.v. (50mgm 2) Day 1, vincristine
i.v. (1 mgm-2) Day 2, cytosine arabinoside i.v.
(80mgm-2) as push injection every 12h Days 3-9.
Bone marrow was evaluated 15-21 days after the
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end of each cycle. Two-4 courses were given,
including one course of consolidation for patients
who achieved complete remission. Treatment was
discontinued after the 3rd cycle in patients who
failed to respond. For maintenance, the majority of
patients received oral thioguanin (70mgm-2) on 4
consecutive days and cytosine arabinoside
subcutaneously (80mgm-2) on the 5th day, weekly
till relapse.
Initial induction treatment for ALL-patients
consisted of adriamycin i.v. (30mgm-2) and
vincristine i.v. (1.4mgm-2) Days 0, 14, 28, 42,
prednisolone by mouth (40mg) daily with or
without L-asparaginase i.v. (10,000 IU m-2) Days 0-
14 followed by either prophylactic or therapeutic
cranial irradiation and intrathecal methotrexate.
Bone marrow was evaluated before each injection of
adriamycin. Remission was maintained with oral
mercaptopurine (75mg daily), oral
cyclophosphamide 300mg/week and oral
methotrexate 30mg/week. Dosages of all drugs were
adjusted to keep the total white blood cell count at
3 x I091- 1. Patients were treated until relapse.
Treatment of relapse was in the majority of cases
identical to the primary induction therapy.
All patients had blood and bone marrow smears
stained by May-Griinwald-Giemsa, PAS,
peroxidase, nonspecific esterase with and without
sodium fluoride, acid phosphatase with and without
tartrate. Complete remission status required the
patient to be in normal health with haemoglobin
>10gmdl -', granulocytes > 1.5 x I091-1, platelets
counts > 100 x IO'I-, and normal bone marrow
cellularity with <5% blast cells. As a rule, clusters
and colonies were studied in both bone marrow
and peripheral blood simultaneously at first
diagnosis, after each course of induction treatment,
at remission, during remission in - 2 month
intervals, and when relapse occurred. Fourteen
patients with AML and 8 with ALL were followed
until relapse and during their reinduction therapy.
Fourteen healthy donors served as normal controls
for the in vitro growth pattern of CFUC in the bone
marrow.
The double-layer agar technique of Pike &
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Table I Clinical characteristics of 50 patients investigated. AML-
patients are listed according to morphology and cytochemistry. M*
refers to the FAB-classification t=one patient with acute mixed
leukaemia but myeloid predominance of leukaemic blasts. ALL is listed
according to immunological marker analysis. $n.d.=not done.
n age (mean) sex (mf)
AML
myeloblastic (M 1+2*) 13
myelomonocytic (M 4*) 12
monoblastic (M 5*) 4 18-79 (50) 15:16
promyelocytic (M 3*) 1
mixedt 1
total 31
ALL
pre-T 4
T 5
c/ALL 4
c/T 1
AUL 1 16-72 (42) 8:11
Burkitt-type 3
n.d.t 1
total 19
Robinson (1970) was used with some minor
modifications. Feeder layers contained 106 blood
mononuclear cells ml- 1, isolated on Isopaque-Ficoll
1.077gml-1, and supplemented with 40% of the
corresponding granulocytes, both obtained from the
same 2 donors throughout the study, in order to
eliminate unpredictable variations in the production
of colony stimulating activity found with different
leukocyte feeder layers. Feeder layers were always
prepared in parallel from both donors. Colony
formation was assayed using 2 standard, increasing
concentrations of patients mononuclear cells:
10 ml- 1 and 2 x l05 ml- 1 for bone marrow,
0.5 x 106 ml-1 and 106 ml - for peripheral blood.
Cultures were scored with an inverted microscope
at x 40 and x 25 magnification for clusters of 3-50
cells or colonies if >50 cells after 10 days. Each
determination represents the mean value of several
dishes. Clusters and colonies were expressed per ml
peripheral blood and bone marrow (Blacket &
Gordon, 1979), taking several variables into account
such as the differential count, absolute number of
leukocytes and the quantity of the specimen
investigated. Heparinized bone marrow (I-2ml)
was obtained by aspiration from the anterior or
posterior iliac crests. Simultaneously, 20ml
heparinized blood was collected. The morphology
of cells within colonies and clusters was not
monitored systematically but in a few cases studied
cultures contained granulocytic cells up to a
metamyelocytic stage.
For the analysis of remission duration and
survival, the life-table method of Cutler and Ederer
was used. Non-parametric variance analysis
according to the H-test of Kruscal and Wallis was
employed to examine the differences in single
pretreatment variables in therapy responsive (R)
and non-responsive (NR) groups of patients as well
as normal individuals. When 2 independent samples
were compared, the Mann-Whitney test was used.
For the analysis of frequencies the X2-test or
Fisher's exact probability test was used. To analyse
the relation of pretreatment characteristics and
length of remission or survival, non-parametric
correlation coefficient was calculated according to
the method of Spearman. The level of significance
in all tests was P<0.05.
Clinical findings are summarized in Table II. The
patient population was unselected, including
antecedent haematological disorders and other
malignancies (pre-leukaemic state 2, refractory
sideroblastic anaemia 1, haemolytic anaemia 1,
aplastic anaemia 1, breast cancer 2, patients older
than 65y (8), and patients with signs of infection
(fever >38°C) at admission. There was no
significant difference in the rate of remission, or
distribution of morphological and growth patterns
among these subgroups.
The number of cluster- or colony-forming cells of
patients with all forms of acute leukaemia varied
over a wide range, particularly in the marrow, at
first presentation. Even so, for both AML and ALL,PROGNOSTIC VALUE OF CFUc IN LEUKAEMIA 425
Table II Treatment results of patients with acute leukaemia after induction (at first diagnosis) and
re-induction (at relapse) therapy. Median remission duration and median survival was calculated
according to life table analysis. R=responder, NR=non-responder, mo=months.
rate ofremission remission duration survival
n (N) (R in mo) (R+NR in mo)
AML
at first diagnosis 31 15 (48) 8 9.4
at relapse 14 8 (57) 3.4 10.4
ALL
at first diagnosis 19 14 (74) 11 7.8
at relapse 8 3 (38) 1 2.8
colony-growth of the bone marrow was significantly
poorer than in normal individuals, while colonies of
the peripheral blood remained within the normal
range. The number of marrow colonies was lowest
after induction treatment, when remission was
achieved, in spite of a normal cellularity and blast
counts <5%. In AML, the bone marrow pool of
colonies recovered 1-2 months after remission
occurred, in ALL after 3-4 months. In both types of
leukaemia, however, it never regained normal values
throughout the observation period of 7-8 months.
The growth pattern of the peripheral blood was
contrary to that of the bone marrow: the number of
colonies continuously decreased and, after 3-4
months were found only sporadically.
At first diagnosis, marrow clusters in AML and
ALL were within normal range, and clusters from
the peripheral blood were significantly above
normal controls. At remission, the number of
clusters in the bone marrow was significantly lower
than before therapy. In contrast to colony-growth,
bone marrow cluster in AML and ALL showed an
overshoot 3-4 months after remission occurred and
remained at normal levels during remission.
Clusters disappeared from the peripheral blood,
although 3-4 months later than colonies. The in
vitro growth pattern of both colonies and clusters in
marrow and blood during relapse was similar to
that at first diagnosis.
AML-patients responding to therapy showed
(Figure 1) less colony-growth and significantly less
cluster-growth in bone marrow and displayed more
frequent negative cultures than those failing to
respond. In contrast, blood cultures (Figure 2) had
significantly more colonies and clusters in the
responder than non-responder group, the latter
containing significantly more negative cultures. In
other words, poor in vitro growth in the bone
marrow and normal or high numbers of CFUC in
the peripheral blood, ensured for AML patients a
good chance of reaching complete remission.
Comparison of remission incidence in marrow and
blood of ALL-patie.its showed that the growth
pattern was opposite to that of patients with AML:
more colony and cluster growth in the bone
marrow and normal growth in the peripheral blood
in patients responding to therapy than in the non-
responder group.
In good agreement with this is the observation
that patients with AML can be expected to have
significantly longer remission (P<0.02) when high
numbers of clusters and colonies are found in the
peripheral blood, before therapy is initiated. No
such correlation existed for patients with ALL prior
to induction therapy. At relapse, however, patients
showing many clusters and/or colonies in the
marrow, had significantly longer remissions (P
=0.03/0.01) than those with poor bone marrow
growth. The pretreatment growth-characteristics
were not of predictive significance for survival in
either AML or Al L.
The degree of marrow infiltration with blast cells
was not of prognostic value. In AML, the mean
values were 65% blasts in the therapy-responsive
compared with 54% in the non-responsive group.
The corresponding figures for ALL patients were
72% and 73%. However in ALL, high blast cell
counts in the bt ne ma-row correlated significantly
with many clusters in the peripheral blood,
indicating a blast cell-dependent mechanism for
emigration of normal progenitor cells from marrow
into the peripher? blood.
There is strong evidence that clusters and
colonies growing an-er the culture conditions used
in this study, are derived from normal residual stem
cells (Metcalf & Moore, 1971; Pike & Robinson,
1970) and not from leukaemic cells (Hoelzer et al.,
1977). Even so, there seems no simple way of
determining the origin of colonies and clusters. In a
recent study (Marie et al., 1981), evidence was
presented that in AML a minority of clusters are
formed from blast cells and some granulopoietic
differentiation may be expressed during blast colony
formation even though morphological evidence of426 U. JEHN et al.
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Figure 1 Distribution of clusters (clu) and colonies (col) per ml bone marrow in normal controls and in
AML-patients at first diagnosis. Values are listed according to whether complete remission was obtained or
not. Responders showed less colonies and significantly less clusters than non-responders (P<0.05).
differentiation is not apparent. We conclude from
the overshooting reappearance of clusters in the
bone marrow 1-2 months after haematological
remission had been reached and from the
continuous disappearance in the peripheral blood
during remission, that the clusters seen in our
experiments represent normal granulopoietic
progenitor cells.
Our observation that clusters found in the bone
marrow of both leukaemias during remission were
far above normal while bone marrow colonies never
return to normal levels, is in good agreement with
the finding (Broxmeyer et al., 1979) of persistent
inhibitory activity against the formation of
granulocyte and macrophage colonies in cultures of
normal bone marrow cells during remission of acute
leukaemia.
All patients followed during induction treatment
showed some reduction in colony-forming ability,
regardless of whether they reached complete
remission or not. The lowest values were found
when patients had recovered from leukopenia and
remission was first diagnosed. This suggests that
cytotoxic drugs affect CFUC with some latency
(Necas et al., 1979; Francis et al., 1981). Colony-
forming capacity reappeared fully
- 1 month after
remission was attained. A second nadir occurred in
association with the antecedent consolidation cycle.
The divergent pattern of blood and marrow
culture growth in our patients with AML and ALL
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Figure 2 Distribution of clusters (clu) and colonies (col) per ml peripheral blood in normal controls and at
first diagnosis. Values are listed according to whether complete remission was obtained or not. Responses
showed significantly more clusters and colonies (P<0.05) than non-responders In addition, the poor-
prognosis group showed significantly (P<0.05) more negative cultures in the peripheral blood than
responders.
in respect of clinical outcome regards some
comment. In agreement with a recent study (Beran
et al., 1980), AML patients showing an increased
number of clones in marrow cultures responded
poorly to therapy, but those with a decreased clone
number, predominantly clusters, and a high
percentage of negative leukaemias achieved
significantly more frequent complete remission. In
the circulating blood, the situation was opposite to
that in bone marrow viz. high numbers of colony
and clusters forming cells and less negative cultures
in the good prognosis group. This relation between
a favourable prognosis in terms of remission
incidence and the presence of colony-forming cells
in the peripheral blood has been noticed earlier
(Hornsten et al., 1977). Furthermore, longer
remissions were much more frequent among AML-
patients whose blood cells showed many colonies
and clusters. In a multivariant analysis of several
pretreatment factors, Keating et al. (1980) found a
similar significant correlation between high numbers
of clusters and long remission. Since on the other
hand, our non-responding group has less colonies
and clusters in the peripheral blood than
responders, one possible explanation of our results
is that in AML the remaining normal
haematopoiesis of those leukaemias which can
respond to therapy deserts the homing bone
marrow and migrates into the peripheral blood.
According to our results such a mechanism would
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be independent of the degree of blast infiltration. In
the poor prognosis group, such an escape of normal
granulopoiesis does not occur and would be
ultimately rejected.
In the ALL-group, although small in size, the
results differed markedly from those found in AML-
patients. The in vitro growth of blood clusters and
colonies remained within nor lal limits, equally in
responsive and non-responsive patients. For ALL-
patients prior to any therapy, there was a definite
trend (although insignifican.) toward achieving
remission and obtaining long remissions when high
CFUC counts were found in the marrow culture.
Both correlations were significant at relapse. Cell
surface characteristics have uncovered a variety of
ALL-subgroups with close correlation to the
prognosis of the disease (Greaves et al., 1978). At
first diagnosis we found 6 different types, but at
relapse only 2 remained. This might explain the
slight discrepancies in significance between the time
of first presentation and relapse. In ALL, no
emigration phenomenon with prognostic relevance
could be observed. However, there was a significant
correlation between blast infiltration of the marrow
and the number of clusters in the peripheral blood
in that, high numbers of blast cells in the bone
marrow implicated high in vitro growth of
peripheral blood.
Although much of the information obtained relies
upon group analysis the conclusion is that,
particularly in AML, and to a minor degree in
ALL, the in vitro growth pattern at diagnosis is a
prognostic indicator of whether or not patients will
respond to chemotherapy and experience long
remissions. A good prognosis in terms of remission
rate and duration does not necessarily imply a long
survival.
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